Goldstein J M, Litwin L C
Department of Pharmacology, ICI Americas Inc., Wilmington, DE 19897.
Eur J Pharmacol. 1988 Oct 11;155(1-2):175-80. doi: 10.1016/0014-2999(88)90419-0.
The effects of acute and chronic treatment with the selective dopamine (DA) D-1 antagonist SCH 23390 on the population response of midbrain DA cells were determined. One hour pretreatment with SCH 23390 (0.0125, 0.025, 0.05 mg/kg s.c.) caused a dose-related increase in the number of spontaneously firing DA neurons in both the A9 and A10 cell regions. Chronic (28 day) administration of SCH 23390 (0.05 mg/kg s.c.) caused depolarization inactivation of only A10 DA cells. These data suggest that SCH 23390 may have antipsychotic properties with a reduced likelihood of producing extrapyramidal side effects.
研究了选择性多巴胺(DA)D-1拮抗剂SCH 23390急性和慢性处理对中脑DA细胞群体反应的影响。用SCH 23390(0.0125、0.025、0.05mg/kg皮下注射)预处理1小时,导致A9和A10细胞区域中自发放电DA神经元的数量呈剂量相关增加。慢性(28天)给予SCH 23390(0.05mg/kg皮下注射)仅导致A10 DA细胞去极化失活。这些数据表明,SCH 23390可能具有抗精神病特性,产生锥体外系副作用的可能性降低。